Who is sponsoring NCT00478036?

NCT00478036 is sponsored by University of Colorado, Denver.

What condition does NCT00478036 study?

NCT00478036 studies Open Angle Glaucoma.

What drugs are being tested in NCT00478036?

Interventions: Acular LS, Pred Forte, Refresh Tears.

What is the status of NCT00478036?

NCT00478036 is currently TERMINATED.

Last reviewed 2016-08-15 · How we verify

A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells.

NCT00478036 NA TERMINATED Results posted

The Investigators will compare, in a randomized, prospective, masked and controlled fashion the effect of a non-steroidal anti-inflammatory agent (Acular LS), a corticosteroid (Pred Forte) and a placebo (Refresh Tears) on patient discomfort, degree of intraocular pressure (IOP) lowering and degree of ocular inflammation following selective laser trabeculoplasty treatment for open angle glaucoma.

Details

Lead sponsor	University of Colorado, Denver
Phase	NA
Status	TERMINATED
Enrolment	31
Start date	2007-05
Completion	2014-01

Conditions

Open Angle Glaucoma

Interventions

Acular LS
Pred Forte
Refresh Tears

Primary outcomes

Interocular Pressure — 8 weeks
IOP, measured by Goldmann applanation tonometry

Countries

United States